Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Division of Cardiovascular and Thoracic Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
J Thorac Cardiovasc Surg. 2014 Feb;147(2):644-51. doi: 10.1016/j.jtcvs.2013.02.014. Epub 2013 Mar 26.
Aortic stenosis is the most common valvular pathology in the elderly. Transcatheter aortic valve replacement has emerged as a safe and feasible alternative for high-risk patients. However, a significant number of patients are still not transcatheter aortic valve replacement candidates because of poor peripheral access and chest pathology. We report the use of alternative access options for such patients.
Seven patients who had poor peripheral access and chest pathology had transcatheter aortic valve replacement using alternative access techniques. Five patients had the valve delivered by direct cannulation of the aorta via a mini-sternotomy, and 1 patient had the valve delivered via a mini-right thoracotomy. In 1 patient, the right subclavian artery was cannulated. Intraprocedural and 30-day outcome data were analyzed.
The mean age of patients was 85.00 ± 9.59 years, with a Society of Thoracic Surgeons score of 16.81% ± 6.87% and logistic European System for Cardiac Operative Risk Evaluation of 21.59% ± 8.46%. Procedural success was 100%. Procedural and 30-day mortality were zero. There were no access-related complications or neurologic events. Two patients had worsening renal function that did not require dialysis. All patients were discharged with a median hospital stay of 7 days. In our experience of 138 transapical or alternative access patients, 7 died (5%) and for 257 transfemoral patients, 1 died (0.4%).
Despite the high surgical risk of the study population, these techniques had excellent outcome with no mortality and acceptable morbidity. With the use of currently available technologies, these approaches are promising and offer alternative options in patients with no access and prohibitive chest pathology or pulmonary function.
主动脉瓣狭窄是老年人最常见的瓣膜病变。经导管主动脉瓣置换术已成为高危患者的一种安全可行的替代方法。然而,由于外周血管条件差和胸廓病变,仍有相当数量的患者不符合经导管主动脉瓣置换术的条件。我们报告了这些患者采用替代入路方法的经验。
7 名外周血管条件差和胸廓病变的患者采用了替代入路技术进行经导管主动脉瓣置换术。5 名患者通过胸骨小切口直接主动脉插管进行瓣膜输送,1 名患者通过微创右胸切开术进行瓣膜输送。1 名患者经右锁骨下动脉插管。分析了术中及 30 天的结果数据。
患者的平均年龄为 85.00±9.59 岁,胸外科医师协会评分(STS)为 16.81%±6.87%,欧洲心脏手术风险评估系统(EuroSCORE)为 21.59%±8.46%。手术成功率为 100%。手术和 30 天死亡率均为 0。无入路相关并发症或神经事件。2 例患者出现肾功能恶化,但无需透析。所有患者中位住院时间为 7 天。在我们 138 例经心尖或替代入路患者的经验中,有 7 例死亡(5%),257 例经股动脉患者中,有 1 例死亡(0.4%)。
尽管研究人群的手术风险较高,但这些技术的结果极好,无死亡,发病率可接受。随着现有技术的应用,这些方法具有很大的应用前景,为无入路条件和禁忌胸廓病变或肺功能的患者提供了替代选择。